Related Experiment Video
Updated: Jul 13, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Congenital myopathies in Israeli families
Karin Weiss1, Yehuda Shapira, Benjamin Glick
1Sourasky Medical Center, Tel-Aviv, Isreal.
Insights
This study describes congenital myopathies in Israeli children, finding that myotubular and nemaline myopathies often present severely. Facial weakness is linked to severe congenital myopathy outcomes.
Area of Science:
- Neurology
- Genetics
- Pediatrics
Background:
- Congenital myopathies are a group of inherited neuromuscular disorders affecting muscle development.
- Understanding the clinical spectrum and genetic factors is crucial for diagnosis and management.
Purpose of the Study:
- To describe the clinical features of congenital myopathies in a cohort of Israeli patients.
- To analyze the prevalence of different congenital myopathy subtypes and their associated phenotypes.
- To identify factors correlating with disease severity, such as age of onset and specific subtypes.
Main Methods:
- Retrospective review of clinical data from 37 patients across 32 Israeli families diagnosed between 1983 and 2004.
- Classification of patients into specific congenital myopathy subtypes: congenital fiber type disproportion, myotubular myopathy, nemaline myopathy, central core disease, actin myopathy, and multi-minicore disease.
- Analysis of clinical presentation, age of onset, family history (consanguinity, recurrence), and phenotype severity.
Main Results:
- The cohort included 13 congenital fiber type disproportion, 10 myotubular myopathy, 7 nemaline myopathy, 5 central core disease, 1 actin myopathy, and 1 multi-minicore disease.
- 84% of patients presented symptoms before 4 months of age; 35% had a severe phenotype (ventilatory dependence or mortality before age 11).
- Myotubular myopathy (60%) and nemaline myopathy (57%) showed high rates of severe phenotypes, unlike congenital fiber type disproportion (23%) and central core disease (0%). Facial weakness was associated with severe outcomes.
Conclusions:
- Congenital myopathies exhibit diverse clinical presentations and varying severity across subtypes in the Israeli population.
- Myotubular and nemaline myopathies are associated with a higher likelihood of severe clinical outcomes.
- Early onset and facial weakness are indicators of potentially severe congenital myopathy.
Abstract:
The clinical features of 37 patients from 32 Israeli families with congenital myopathies evaluated between 1983 and 2004 are described: 13 children were diagnosed with congenital fiber type disproportion, 10 had myotubular myopathy, 7 had nemaline myopathy, 5 had central core disease, 1 had actin myopathy, and 1 had multi-minicore disease. There were 7 families (22%) that had parental consanguinity, and 4 families (12%) had more than 1 patient with congenital myopathy. Of the patients, 31 (84%) presented with clinical symptoms before 4 months of age, and 6 children (16%) presented after 1 year of age. Thirteen children (35%) had a severe phenotype with chronic ventilatory dependence or mortality before the age of 11 years. Facial weakness was associated with a severe phenotype. There was a high rate of a severe clinical phenotype in patients with myotubular myopathy (60%) and in patients with nemaline myopathy (57%), whereas in patients with congenital fiber type disproportion and in patients with central core disease, the proportion of a severe phenotype was lower (23% and 0%, respectively).
Related Concept Videos
Animal Mitochondrial Genetics
Inborn Errors of Metabolism
Sex-linked Disorders
Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Satellite Stem Cells and Muscular Dystrophy
Cardiomyopathy III: Hypertrophic Cardiomyopathy

